Some groups have demonstrated that in ovarian-cancer tumor-tissue sections, intraepithelial CD8+ TILs correlate with good outcome, and others have shown that a high ratio of CD8+/FoxP3+ T regulatory cells (Tregs) is beneficial to survival [17]. This evidence concerns the gene CD8A and ovarian carcinoma.